Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

60.46
-0.1000-0.17%
Volume:155.73K
Turnover:9.47M
Market Cap:5.84B
PE:-12.85
High:61.67
Open:61.01
Low:60.38
Close:60.56
52wk High:72.66
52wk Low:35.60
Shares:96.64M
Float Shares:95.45M
Volume Ratio:0.28
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:4.70
PE(LYR):-13.85

Loading ...

Xenon Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
May 08

Needham Reaffirms Their Buy Rating on Xenon (XENE)

TIPRANKS
·
May 08

H.C. Wainwright Remains a Buy on Xenon (XENE)

TIPRANKS
·
May 08

Xenon Pharmaceuticals Q1 Loss Widens

MT Newswires Live
·
May 08

Earnings Flash (XENE) Xenon Pharmaceuticals Posts Q1 Per Share Loss $1.17, vs. FactSet Est of Loss $1.18

MT Newswires Live
·
May 08

Xenon Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Canada's Xenon reports Q1 net loss slightly better than expected

Reuters
·
May 08

Xenon Pharmaceuticals Q1 EPS $(1.17) Beats $(1.20) Estimate, Cash, Cash Equivalents And Marketable Securities Of $1.3B Extends Cash Runway Into 2029

Benzinga Earnings
·
May 08

Xenon Q1 net loss widens to $102.3 million; R&D expenses climb to $88.5 million

Reuters
·
May 08

BRIEF-Xenon Pharmaceuticals Q1 Net Income USD -102.302 Million Vs. IBES Estimate USD -102.8 Million

Reuters
·
May 08

Xenon Pharmaceuticals Q1 Operating Expenses USD 112.328 Million

THOMSON REUTERS
·
May 08

Xenon Reports Q1 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 08

Xenon reports inducement grants of 25,600 options, 15,000 RSUs to new hires

Reuters
·
May 02

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 02

Xenon (XENE) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
Apr 28

Is Xenon Pharmaceuticals (XENE) Attractive After Recent Pullback And Strong One Year Rally

Simply Wall St.
·
Apr 25

What Xenon Pharmaceuticals (XENE)'s Positive Phase 3 X-TOLE2 Epilepsy Data Means For Shareholders

Simply Wall St.
·
Apr 22

Analysts Are Bullish on Top Healthcare Stocks: Xenon (XENE), Biogen (BIIB)

TIPRANKS
·
Apr 20

Xenon Pharmaceuticals presents data from Phase 3 X-TOLE2 study

TIPRANKS
·
Apr 20

Xenon says Phase 3 X-TOLE2 trial shows azetukalner cuts monthly seizures 53%

Reuters
·
Apr 20